Neoadjuvant therapy for localized pancreatic cancer: guiding principles

Por Fathi, Amir, Christians, Kathleen K., George, Ben, Ritch, Paul S., Erickson, Beth A., Tolat, Parag, Johnston, Fabian M., Evans, Douglas B., Tsai, Susan
Publicado no J Gastrointest Oncol (2015)

Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

Por Aldakkak, Mohammed, Christians, Kathleen K, Krepline, Ashley N, George, Ben, Ritch, Paul S, Erickson, Beth A, Johnston, Fabian M, Evans, Douglas B, Tsai, Susan
Publicado no HPB (Oxford) (2015)

RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Patients with Locally Advanc...

Por Wong, Stuart J., Winter, Kathryn, Meropol, Neal J., Anne, Pramila Rani, Kachnic, Lisa, Rashid, Asif, Watson, James C., Mitchell, Edith, Pollock, Jondavid, Lee, R. Jeffrey, Haddock, Michael, Erickson, Beth A., Willett, Christopher G.
Publicado em 2011

Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patien...

Por Wong, Stuart J., Moughan, J., Meropol, Neal J., Anne, Pramila Rani, Kachnic, Lisa A., Rashid, Asif, Watson, James C., Mitchell, Edith P., Pollock, Jondavid, Lee, R. Jeffrey, Haddock, Michael, Erickson, Beth A., Willett, Christopher G.
Publicado no Int J Radiat Oncol Biol Phys (2014)